查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1597811

猪疫苗市场：按产品类型、目标疾病划分 - 2025-2030 年全球预测

Swine Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease), Target Disease - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年猪疫苗市值为14.7亿美元，预计2024年将达15.8亿美元，复合年增长率为7.54%，预计2030年将达24.5亿美元。

猪疫苗市场是指用于预防和控制猪传染病的疫苗的生产、分销和应用，主要是为了维持猪的健康、确保生物安全并支持永续的猪肉生产。这些疫苗用于预防多种疾病，包括猪繁殖与呼吸综合症（PRRS）、猪流感和霉浆菌。最终使用者主要是兽医医院、养猪场和畜牧设施。关键的成长要素包括猪病发病率的增加、全球猪肉产品需求的增加以及对动物健康和福祉的认识不断提高。重组 DNA 技术等技术进步和次单位疫苗疫苗和 DNA 疫苗等新型疫苗的开拓进一步塑造了市场动态，这带来了潜在的商机，特别是对于投资于研发和战略伙伴关係的公司。然而，挑战包括严格的法律规范、疫苗开发和生产的高成本以及饲料和其他牲畜必需品的价格波动，这些可能会阻碍市场扩张。此外，它们还面临疫苗功效变化和新病原体出现的限制。因此，创新领域包括开发具有更广泛频谱的疫苗、提高疫苗稳定性和储存条件，以及整合用于疾病监测和疫苗管理的数位工具。为了利用这些机会，公司应优先投资于尖端研究、全球分销网络以及对监管环境的透彻了解。快速变化的市场条件和竞争需要灵活的策略来适应新的科学发现和消费者需求，并确保动物健康、永续性和经济可行性之间的平衡。

主要市场统计
基准年[2023] 14.7亿美元
预计年份 [2024] 15.8亿美元
预测年份 [2030] 24.5亿美元
复合年增长率（%） 7.54%

市场动态：揭示快速发展的猪隻疫苗市场的关键市场洞察

供需的动态交互作用正在改变猪隻疫苗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 猪肉消费增加
    • 人们对牲畜健康的认识不断增强
  • 市场限制因素
    • 疫苗供应有限
  • 市场机会
    • 新疫苗开发的研究与开发
  • 市场挑战
    • 兽医短缺

波特的五力战略工具驾驭猪疫苗市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解猪隻疫苗市场的外部影响

外部宏观环境因素对猪隻疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解猪隻疫苗市场竞争状况

对猪疫苗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵猪疫苗市场供应商绩效评估

FPNV定位矩阵是评估猪隻疫苗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了猪疫苗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对猪疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 猪肉消费量增加
      • 人们对牲畜健康的认识不断增强
    • 抑制因素
      • 疫苗供应有限
    • 机会
      • 新疫苗开发的研究与开发
    • 任务
      • 兽医短缺
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章猪疫苗市场：副产品

  • 减毒活病毒疫苗
  • DNA疫苗
  • 灭活疫苗
  • 重组疫苗
  • 次单位疫苗

第七章猪疫苗市场：依类型

  • 胸膜肺炎放线桿菌
  • 猪瘟
  • 手足口病
  • M·豹子
  • 佩多夫
  • 猪环状病毒2型
  • 猪细小病毒
  • 抗逆转录病毒药物
  • 伪狂犬病
  • 猪流感

第八章猪疫苗市场目标疾病

  • 关节炎
  • 博德特菌性鼻炎
  • 腹泻
  • 手足口病
  • 猪环状病毒相关疾病
  • 猪繁殖与呼吸综合症
  • 伪狂犬病
  • 猪流感

第九章美洲猪疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太猪疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲猪疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Bayer AG
  • Ceva Sante Animale
  • China, Jinyu Bio-technology Co., Ltd.
  • Covetrus Inc.
  • Dechra Pharmaceuticals plc
  • Elanco Animal Health Incorporated
  • HIPRA
  • Huvepharma EOOD
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd
  • Merck & Co., Inc.
  • Phibro Animal Health
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-3A2E844FD486

The Swine Vaccines Market was valued at USD 1.47 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 2.45 billion by 2030.

The swine vaccines market is defined by the production, distribution, and application of vaccines that aim to prevent and control infectious diseases in pigs, primarily driven by the necessity to maintain swine health, ensure biosecurity, and support sustainable pork production. The application of these vaccines spans across various diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, and Mycoplasma, to name a few. End-users predominantly encompass veterinary clinics, swine farms, and animal husbandry facilities. Key growth factors include the increasing incidence of swine diseases, rising demand for pork products globally, and heightened awareness regarding animal health and welfare. Market dynamics are further shaped by technological advancements such as recombinant DNA technology and the development of newer vaccine types such as subunit and DNA vaccines, presenting potential opportunities particularly for companies investing in R&D and strategic partnerships. However, challenges include stringent regulatory frameworks, high costs associated with vaccine development and production, and the fluctuating prices of feed and other livestock essentials, which can hinder market expansion. Moreover, the industry faces limitations due to varying vaccine efficacy and the emergence of novel pathogens. Consequently, areas ripe for innovation include the development of vaccines with broader spectrums of action, enhancing vaccine stability and storage conditions, and the integration of digital tools for disease monitoring and vaccine management. To capitalize on these opportunities, businesses should prioritize investment in cutting-edge research, global distribution networks, and a thorough understanding of the regulatory landscape. The swine vaccines market is characterized by rapid advancements and a competitive landscape, demanding agile strategies to adapt to new scientific findings and consumer needs, ensuring a robust balance between animal health, sustainability, and economic viability.

KEY MARKET STATISTICS
Base Year [2023] USD 1.47 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.45 billion
CAGR (%) 7.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Swine Vaccines Market

The Swine Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising consumption of pork meat
    • Growing awareness related to livestock health
  • Market Restraints
    • Limited availability of vaccine
  • Market Opportunities
    • R&D for novel vaccine developments
  • Market Challenges
    • Dearth of veterinary practitioners

Porter's Five Forces: A Strategic Tool for Navigating the Swine Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Swine Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Swine Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Swine Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Swine Vaccines Market

A detailed market share analysis in the Swine Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Swine Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Swine Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Swine Vaccines Market

A strategic analysis of the Swine Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Swine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Ceva Sante Animale, China, Jinyu Bio-technology Co., Ltd., Covetrus Inc., Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, HIPRA, Huvepharma EOOD, IDEXX Laboratories, Inc., Indian Immunologicals Ltd, Merck & Co., Inc., Phibro Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Swine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.
  • Based on Type, market is studied across Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, M. Hyo, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, and Swine Influenza.
  • Based on Target Disease, market is studied across Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, and Swine Influenza.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising consumption of pork meat
      • 5.1.1.2. Growing awareness related to livestock health
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of vaccine
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D for novel vaccine developments
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of veterinary practitioners
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Swine Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccines
  • 6.3. DNA Vaccines
  • 6.4. Inactivated Vaccines
  • 6.5. Recombinant Vaccines
  • 6.6. Subunit Vaccines

7. Swine Vaccines Market, by Type

  • 7.1. Introduction
  • 7.2. Actinobacillus Pleuropneumoniae
  • 7.3. Classical Swine Fever
  • 7.4. Foot & Mouth Disease
  • 7.5. M. Hyo
  • 7.6. PEDV
  • 7.7. Porcine Circovirus Type 2
  • 7.8. Porcine Parvovirus
  • 7.9. PRRS
  • 7.10. Pseudorabies
  • 7.11. Swine Influenza

8. Swine Vaccines Market, by Target Disease

  • 8.1. Introduction
  • 8.2. Arthritis
  • 8.3. Bordetella Rhinitis
  • 8.4. Diarrhea
  • 8.5. Foot & Mouth Disease
  • 8.6. Porcine Circovirus Associated Disease
  • 8.7. Porcine Reproductive & Respiratory Syndrome
  • 8.8. Pseudorabies
  • 8.9. Swine Influenza

9. Americas Swine Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Swine Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Swine Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. Ceva Sante Animale
  • 3. China, Jinyu Bio-technology Co., Ltd.
  • 4. Covetrus Inc.
  • 5. Dechra Pharmaceuticals plc
  • 6. Elanco Animal Health Incorporated
  • 7. HIPRA
  • 8. Huvepharma EOOD
  • 9. IDEXX Laboratories, Inc.
  • 10. Indian Immunologicals Ltd
  • 11. Merck & Co., Inc.
  • 12. Phibro Animal Health
  • 13. Vetoquinol S.A.
  • 14. Virbac S.A.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. SWINE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. SWINE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SWINE VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY ACTINOBACILLUS PLEUROPNEUMONIAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY M. HYO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY PEDV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS TYPE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY PRRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY BORDETELLA RHINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 87. THAILAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. VIETNAM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. VIETNAM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. DENMARK SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. DENMARK SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. DENMARK SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. EGYPT SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EGYPT SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EGYPT SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. FINLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. FINLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. FINLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. FRANCE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. FRANCE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. FRANCE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. GERMANY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. GERMANY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. GERMANY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. ISRAEL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. ISRAEL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ISRAEL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. ITALY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. ITALY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. ITALY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. NETHERLANDS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. NIGERIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. NIGERIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. NIGERIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. NORWAY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. NORWAY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. NORWAY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. POLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. POLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. POLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. QATAR SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. QATAR SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. QATAR SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. RUSSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. RUSSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. RUSSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. SPAIN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SPAIN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SPAIN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. SWEDEN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SWEDEN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SWEDEN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 148. SWITZERLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. TURKEY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. TURKEY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TURKEY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 160. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 161. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023